Phase II Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ

Conditions:   Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: Atezolizumab;   Drug: 5-Fluorouracil;   Drug: Calciumfolinat;   Drug: Oxaliplatin;   Drug: Docetaxel
Sponsor:   IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest
Not yet recruiting

http://ift.tt/2GRY8nM